HAVAH Therapeutics SARM+Ai mammographic breast density reduction
A Phase II single-centre study investigating the efficacy and safety of GTx-024 and anastrozole in peri-menopausal women with high mammographic breast density.
A Phase II single-centre study investigating the efficacy and safety of GTx-024 and anastrozole in peri-menopausal women with high mammographic breast density.
Sorry, comments for this entry are closed at this time.